Author:
Uslu Yasemin,Kocatepe Vildan,Sezgin Derya Subaşı,Uras Cihan
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Early Breast Cancer Trialists’ Collaborative Group (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. The Lancet Lancet Publishing Group 386:1341–1352
2. Early Breast Cancer Trialists’ Collaborative Group (2011) Relevance of breast cancer hormone receptors and other factors to the effi cacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378:771–784
3. Ekinci E, Nathoo S, Korattyil T, Vadhariya A, Zaghloul HA, Niravath PA et al (2018) Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence? J Cancer Surviv 12:348–356
4. Hershman DL, Shao T, Kushi LH, Buono D, Yann Tsai W, Fehrenbacher L et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529–537
5. He W, Eriksson L, Törnberg S, Strand F, Czene K (2019) Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening. BMC Med 17:1–9
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献